440
Participants
Start Date
February 20, 2018
Primary Completion Date
December 9, 2019
Study Completion Date
August 16, 2021
Baricitinib
Administered orally
Placebo
Administered orally
Icahn School of Medicine at Mount Sinai, New York
DermResearchCenter of New York, Inc, Stony Brook
Dermatology and Skin Surgery Center, Exton
GWU/Medical Faculty Associates, Washington D.C.
Dermatology and Skin Cancer Specialists, Rockville
Virginia Clinical Research, Norfolk
Dermatology & Laser Center of Charleston, Charleston
Medical University of South Carolina, Charleston
Advanced Medical Research, Sandy Springs
Dermatologic Surgery Specialists, PC, Macon
Meridian Clinical Research, Savannah
Solutions Through Advanced Research, Inc., Jacksonville
Riverchase Dermatology and Cosmetic Surgery, Pembroke Pines
Miami Dermatology & Laser Research, Miami
University of South Florida, Tampa
ForCare Clinical Research, Tampa
Olympian Clinical Research, Largo
University of Alabama at Birmingham, Birmingham
Dermatology Specialist, Louisville
Bexley Dermatology Research, Bexley
University Hospitals Cleveland Medical Center, Cleveland
Dermatologists of Southwest Ohio, Inc., Mason
Wright State Univ School of Medicine, Fairborn
The Indiana Clinical Trials Center, PC, Plainfield
Dawes Fretzin Clinical Research, Indianapolis
The South Bend Clinic, South Bend
Hamzavi Dermatology, Fort Gratiot
Great Lakes Research Group, Inc., Bay City
Arlington Dermatology, Rolling Meadows
University Dermatology, Darien
Northwestern University, Chicago
Central Dermatology PC, St Louis
Skin Specialists, P.C, Omaha
Johnson Dermatology, Fort Smith
Modern Research Associates PLLC, Dallas
Bellaire Dermatology, Bellaire
Acclaim Dermatology, PLLC, Sugar Land
Texas Dermatology and Laser Specialists, San Antonio
Austin Institute for Clinical Research, Inc., Pflugerville
Treasure Valley Dermatology, Boise
University of Utah MidValley Dematology, Murray
Keck School of Medicine University of Southern California, Los Angeles
Wallace Medical Group, Inc., Beverly Hills
Clinical Science Institute, Santa Monica
California Dermatology and Clinical Research Institute, Encinitas
Medical Center for Clinical Research, San Diego
University Clinical Trials, Inc., San Diego
Southern California Dermatology, Santa Ana
Tien Q. Nguyen, MD inc. DBA First OC Dermatology, Fountain Valley
Center for Dermatology Clinical Research, Inc., Fremont
Care Access Research-Walnut Creek, Walnut Creek
University of California Davis-Dermatology, Sacramento
Oregon Dermatology and Research Center, Portland
OHSU Center for Health and Healing, Portland
Multicare Health System, Tacoma
Clinical Research Center of CT/NY, Danbury
Univ of Connecticut, Farmington
Tufts Medical Center, Boston
Brigham and Womens Hospital, Boston
Clinical Partners LLC, Johnston
Kirk Barber Research, Calgary
Institute for Skin Advancement, Calgary
Stratica Medical, Edmonton
Dr. Chih-ho Hong Medical Inc., Surrey
Enverus Medical Research, Surrey
Simcoderm Medical & Surgical Dermatology Centre, Barrie
Kingsway Clinical Research, Etobicoke
Medicor Research Inc, Greater Sudbury
Lynderm Research Inc, Markham
Allergy Research Canada Inc., Niagara Falls
SKiN Centre for Dermatology, Peterborough
The Centre for Dermatology, Richmond Hill
K. Papp Clinical Research Inc, Waterloo
XLR8 Medical Research, Windsor
Innovaderm Research Inc, Montreal
Centre de Recherche Dermatologique de Quebec Metropolitain, Québec
York Dermatology Center, Richmond Hill
Office of Dr. Samuel Sanchez PSC, Caguas
Office of Dr. Alma M. Cruz, Carolina
Ponce School of Medicine CAIMED Center, Ponce
GCM Medical Group PSC, San Juan
Collaborators (1)
Incyte Corporation
INDUSTRY
Eli Lilly and Company
INDUSTRY